US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

GSK plc ADRhedged

71.56

-0.7881-1.09%

Post-market: 71.30-0.2619-0.37%16:10 EDT

Volume:212

Turnover:15.12K

Market Cap:715.69K

PE:- -

High:71.56

Open:71.36

Low:71.30

Close:72.35

52wk High:85.03

52wk Low:55.03

Shares:10.00K

Float Shares:10.00K

Volume Ratio:0.50

T/O Rate:2.12%

Dividend:2.08

Dividend Rate:2.90%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

GlaxoSmithKline (GSK) Gets a Buy from Jefferies

GSK boosts treasury stock as buyback lifts voting share base

GSK Emerges as Unexpected Winner From American Oncology Conference -- Market Talk

Analysts Conflicted on These Healthcare Names: GlaxoSmithKline (GB:GSK) and C4 Therapeutics (CCCC)

GlaxoSmithKline (GSK) Gets a Hold from UBS

SBP GROUP (01177) Rises Over 4% as Bepirovirsen Co-developed with GlaxoSmithKline PLC to Unveil Two Phase III Clinical Data at EASL 2026

Sino Biopharm, GSK Report Pivotal Phase III Success for Hepatitis B Drug Bepirovirsen

GSK’s mRNA Flu Vaccine Trial Reaches Key Phase 2 Milestone, Eyeing Next-Gen Seasonal Market

GSK Trial Data Show Functional Cure Rates For Hepatitis B Treatment

MT Newswires Live

Ionis partner GSK reports B-Well 1, B-Well 2 trials meet primary endpoint

GSK Says Hepatitis B Drug Candidate Cured Some Patients in Late-Stage Trials

GSK’s bepirovirsen delivers landmark functional cure rates in chronic hepatitis B phase III trials

Positive Report for GlaxoSmithKline (GSK) from Kepler Capital

GSK’s Long-Acting HIV Study Nears the Finish Line: What Investors Should Watch

GSK Discloses Notional ADS Purchase by US President Martinez-Davis

GlaxoSmithKline (GSK) Receives a Hold from Deutsche Bank

GlaxoSmithKline (GSK) Receives a Buy from Jefferies

GSK to present new data from portfolio, pipeline at ASCO Annual Meeting

GSK boosts treasury stock as buyback programme passes 3.3 million shares

GSK Adds Shares to Market Under Employee Save Plan

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/GSKH/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GSKH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GSKH\",,,,,undefined,":{"symbol":"GSKH","market":"US","secType":"STK","nameCN":"GSK plc ADRhedged","latestPrice":71.5619,"timestamp":1787601600000,"preClose":72.35,"halted":0,"volume":212,"hourTrading":{"tag":"盘后","latestPrice":71.3,"preClose":71.5619,"latestTime":"16:10 EDT","volume":6,"amount":429.3714,"timestamp":1787602204676,"change":-0.2619,"changeRate":-0.00366,"amplitude":0},"delay":0,"changeRate":-0.01089288182446441,"floatShares":10001,"shares":10001,"eps":0,"marketStatus":"Not Yet Opened","change":-0.7881,"latestTime":"08-24 16:00:00 EDT","open":71.36,"high":71.5619,"low":71.3,"amount":15118,"amplitude":0.00362,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787644800000},"marketStatusCode":0,"adr":0,"exchange":"ARCA","adjPreClose":72.35,"nav":72.35762,"aum":723648.55762,"dividendRate":0.029015,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":71.3,"preClose":71.5619,"latestTime":"16:10 EDT","volume":6,"amount":429.3714,"timestamp":1787602204676,"change":-0.2619,"changeRate":-0.00366,"amplitude":0},"volumeRatio":0.503563,"impliedVol":0.1195,"impliedVolPercentile":0.19},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GSKH\",,,,,undefined,":{"symbol":"GSKH","floatShares":10001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.503563,"shares":10001,"dividePrice":2.0764,"high":71.5619,"amplitude":0.00362,"preClose":72.35,"low":71.3,"week52Low":55.03,"pbRate":"--","week52High":85.03,"institutionHeld":0,"latestPrice":71.5619,"eps":0,"divideRate":0.029015,"volume":212,"delay":0,"ttmEps":0,"open":71.36,"prevYearClose":68.2031,"prevWeekClose":72.35,"prevMonthClose":71.6488,"prevQuarterClose":73.8574,"fiveDayClose":69.8844,"twentyDayClose":72.7499,"sixtyDayClose":72.3943},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GSKH\",params:#limit:5,,,undefined,":[{"date":"2026-06-16","symbol":"GSKH","amount":0.92785,"announcedDate":"2026-06-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-16","defaultRemindTime":1781616600000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-23","payableDate":"2026-06-16","currency":"USD","dateTimestamp":1781582400000,"payDate":"2026-06-23"},{"date":"2026-03-16","symbol":"GSKH","amount":0.36332,"announcedDate":"2026-03-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-16","defaultRemindTime":1773667800000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-23","payableDate":"2026-03-16","currency":"USD","dateTimestamp":1773633600000,"payDate":"2026-03-23"},{"date":"2025-12-16","symbol":"GSKH","amount":0.78682,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-24"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GSKH\",market:\"US\",,,undefined,":[{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-24","value":0.78682,"currency":"USD"},{"executeDate":"2026-03-16","recordDate":"2026-03-16","paymentDate":"2026-03-23","value":0.36332,"currency":"USD"},{"executeDate":"2026-06-16","recordDate":"2026-06-16","paymentDate":"2026-06-23","value":0.92785,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GSKH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GSKH\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2640821661","title":"GlaxoSmithKline (GSK) Gets a Buy from Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2640821661","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640821661?lang=en_us&edition=fundamental","pubTime":"2026-06-04 05:25","pubTimestamp":1780521915,"startTime":"0","endTime":"0","summary":"Jefferies analyst Michael Leuchten maintained a Buy rating on GlaxoSmithKline today and set a price target of £25.00. According to TipRanks, Leucht...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-gets-a-buy-from-jefferies-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-gets-a-buy-from-jefferies-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","GSK.UK","GSK","LU1829250122.USD","BK4588","BK4585","GSKH","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640950348","title":"GSK boosts treasury stock as buyback lifts voting share base","url":"https://stock-news.laohu8.com/highlight/detail?id=2640950348","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640950348?lang=en_us&edition=fundamental","pubTime":"2026-06-01 22:16","pubTimestamp":1780323389,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ( ($GB:GSK) ) just unveiled an announcement. GSK has continued its share buyback programme, repurchasing just under 1.25 million or...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-boosts-treasury-stock-as-buyback-lifts-voting-share-base?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-boosts-treasury-stock-as-buyback-lifts-voting-share-base?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","US10Y.BOND","TLTW","US2Y.BOND","US12M.BOND","US30Y.BOND","US7Y.BOND","GSK","GSK.UK","TLT","US3Y.BOND","BK4532","GSKH","US5Y.BOND","TMF","BK4585","LU1829250122.USD","US6M.BOND","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640930291","title":"GSK Emerges as Unexpected Winner From American Oncology Conference -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2640930291","media":"Dow Jones","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640930291?lang=en_us&edition=fundamental","pubTime":"2026-06-01 17:53","pubTimestamp":1780307580,"startTime":"0","endTime":"0","summary":"0953 GMT - U.K. drugmaker GSK came out as an unexpected winner from a big U.S. oncology conference, Jefferies analysts say in a note. Early-stage data for GSK's drug candidate IDRx-42 presented at the American Society of Clinical Oncology's annual meeting showed potential as a first-line treatment for gastrointestinal cancer, Jefferies says. Moreover, updates from rivals on new ovarian-cancer drugs didn't top those of GSK's own candidate Mo-Rez, the analysts say. Competition in the market for drugs to treat ovarian cancer resistant to platinum-based chemotherapy is heating up, they add. GSK's Mo-Rez and NaPi2b--developed by Tubulis, which was recently acquired by Gilead Sciences--might be setting the bar for the disease, while AstraZeneca's Puxi-Sam doesn't look as competitive, according to Jefferies. GSK shares fall 0.3%. ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BK4007","BK4588","GSKH","BK4107","BK4585","GSK.UK","LU1829250122.USD","BK4117","GSK","AFG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639606232","title":"Analysts Conflicted on These Healthcare Names: GlaxoSmithKline (GB:GSK) and C4 Therapeutics (CCCC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2639606232","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639606232?lang=en_us&edition=fundamental","pubTime":"2026-05-30 17:02","pubTimestamp":1780131770,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on GlaxoSmithKline (GB:GSK) and C4 Therapeutics (CCCC). GlaxoSmithKl...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-glaxosmithkline-gbgsk-and-c4-therapeutics-cccc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-glaxosmithkline-gbgsk-and-c4-therapeutics-cccc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","GSKH","LU0029874061.USD","LABU","BK4007","LU1829250122.USD","BK4532","BK4137","GSK","XLV","CCCC","GSK.UK","XBI","BK4581","HCSG","BK4588","BK4585","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639693623","title":"GlaxoSmithKline (GSK) Gets a Hold from UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2639693623","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639693623?lang=en_us&edition=fundamental","pubTime":"2026-05-29 17:00","pubTimestamp":1780045236,"startTime":"0","endTime":"0","summary":"UBS analyst Matthew Weston maintained a Hold rating on GlaxoSmithKline today and set a price target of p1,940.00. According to TipRanks, Weston is ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-gets-a-hold-from-ubs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-gets-a-hold-from-ubs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4118","GSKH","IE0034235071.USD","LU1863844665.USD","BK4534","BK4007","GSK.UK","LU3187612489.SGD","BK4532","LU1863844749.USD","GSK","UBS","BK4585","BK4588","LU1829250122.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136878581","title":"SBP GROUP (01177) Rises Over 4% as Bepirovirsen Co-developed with GlaxoSmithKline PLC to Unveil Two Phase III Clinical Data at EASL 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1136878581","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136878581?lang=en_us&edition=fundamental","pubTime":"2026-05-29 14:38","pubTimestamp":1780036715,"startTime":"0","endTime":"0","summary":"SBP GROUP (01177) rose over 4%, up 3.95% at the time of writing, trading at HK$5 with a turnover of HK$428 million. On May 29, SBP GROUP announced that Bepirovirsen, co-developed by its subsidiary,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK1521","VXUS","GSK.UK","BK4134","BK4585","GSKH","BK1589","01177","GSK","BK1515","III","IE00BZ08YT58.USD","IE00BZ08YS42.EUR","LU1829250122.USD","IE00BZ08YR35.GBP","BK1191","HK0000165453.HKD","BK4007","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639612379","title":"Sino Biopharm, GSK Report Pivotal Phase III Success for Hepatitis B Drug Bepirovirsen","url":"https://stock-news.laohu8.com/highlight/detail?id=2639612379","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639612379?lang=en_us&edition=fundamental","pubTime":"2026-05-29 07:38","pubTimestamp":1780011524,"startTime":"0","endTime":"0","summary":"Sino Biopharmaceutical ( ($HK:1177) ) has provided an update. Sino Biopharmaceutical said its subsidiary Chia Tai Tianqing and partner GSK have rep...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sino-biopharm-gsk-report-pivotal-phase-iii-success-for-hepatitis-b-drug-bepirovirsen?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sino-biopharm-gsk-report-pivotal-phase-iii-success-for-hepatitis-b-drug-bepirovirsen?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK.UK","BK4007","LU1829250122.USD","BK4134","GSK","BK4585","III","BK4532","GSKH","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639697287","title":"GSK’s mRNA Flu Vaccine Trial Reaches Key Phase 2 Milestone, Eyeing Next-Gen Seasonal Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2639697287","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639697287?lang=en_us&edition=fundamental","pubTime":"2026-05-29 00:30","pubTimestamp":1779985844,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. GSK’s latest update covers a Phase 2a trial titled “A Phase 2a Randomiz...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsks-mrna-flu-vaccine-trial-reaches-key-phase-2-milestone-eyeing-next-gen-seasonal-market?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsks-mrna-flu-vaccine-trial-reaches-key-phase-2-milestone-eyeing-next-gen-seasonal-market?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK","BK4532","GSKH","LU1829250122.USD","BK4585","BK4007","GSK.UK","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638667291","title":"GSK Trial Data Show Functional Cure Rates For Hepatitis B Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2638667291","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638667291?lang=en_us&edition=fundamental","pubTime":"2026-05-28 19:05","pubTimestamp":1779966331,"startTime":"0","endTime":"0","summary":"GSK's  pooled data from two phase 3 clinical trials showed that experimental medicine bepirovirsen achieved a 19% functional cure response rate in individuals with chronic hepatitis B, the drugmaker said Thursday.The therapy reached a 26% cure rate among patients exhibiting lower baseline viral activity compared with no cures in the placebo group, the company said.GSK said it anticipates regulatory approvals in Q3.An exploratory evaluation also indicated nearly half of the participants maintained low surface antigen levels a year after finishing the regimen, GSK said.The medication demonstrated a tolerable safety profile during the trials, with common side effects including temporary liver enzyme elevation and localized injection site pain, GSK said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","GSKH","BK4585","BK4532","GSK.UK","LU1829250122.USD","BK4007","GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638696556","title":"Ionis partner GSK reports B-Well 1, B-Well 2 trials meet primary endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2638696556","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638696556?lang=en_us&edition=fundamental","pubTime":"2026-05-28 17:21","pubTimestamp":1779960078,"startTime":"0","endTime":"0","summary":"Ionis Pharmaceuticals (IONS) partner GSK (GSK) announced data for bepirovirsen, an investigational antisense oligonucleotide for the treatment of c...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ionis-partner-gsk-reports-b-well-1-b-well-2-trials-meet-primary-endpoint-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ionis-partner-gsk-reports-b-well-1-b-well-2-trials-meet-primary-endpoint-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4585","BK4139","GSK.UK","BK4588","GSK","LU1829250122.USD","IONS","GSKH","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638263665","title":"GSK Says Hepatitis B Drug Candidate Cured Some Patients in Late-Stage Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2638263665","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638263665?lang=en_us&edition=fundamental","pubTime":"2026-05-28 16:39","pubTimestamp":1779957540,"startTime":"0","endTime":"0","summary":"GSK said a drug candidate for hepatitis B helped nearly a fifth of patients who enrolled in two late-stage clinical trials achieve a functional cure.The U.K. drugmaker on Thursday released results from two phase 3 trials for the drug, bepirovirsen, which showed 19% of hepatitis B patients achieved a functional cure response rate in the overall study population after a six-month treatment. The drug delivered a functional cure rate of 26% in a smaller group of patients with lower viral activity, the company said.GSK is looking to speed up the launch of the medicines it has in the pipeline, as part of GSK Chief Executive Luke Miels' plan to offset upcoming patent expirations. Miels singled out bepirovirsen in a recent earnings call, saying it would materially change the treatment of hepatitis B.Hepatitis B is a serious liver infection, which can lead to liver damage, cancer and death. GSK said the drug has potential to redefine the treatment of a disease for which the current standard of ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BK4585","BK4007","SSI","GSK.UK","BK4588","LU1829250122.USD","GSK","GSKH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638766503","title":"GSK’s bepirovirsen delivers landmark functional cure rates in chronic hepatitis B phase III trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2638766503","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638766503?lang=en_us&edition=fundamental","pubTime":"2026-05-28 16:32","pubTimestamp":1779957142,"startTime":"0","endTime":"0","summary":"An update from GlaxoSmithKline ( ($GB:GSK) ) is now available. GSK reported pivotal phase III data showing its investigational antisense oligonucle...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsks-bepirovirsen-delivers-landmark-functional-cure-rates-in-chronic-hepatitis-b-phase-iii-trials?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsks-bepirovirsen-delivers-landmark-functional-cure-rates-in-chronic-hepatitis-b-phase-iii-trials?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4134","BK4532","GSK.UK","BK4007","GSK","GSKH","LU1829250122.USD","BK4585","III","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638634636","title":"Positive Report for GlaxoSmithKline (GSK) from Kepler Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2638634636","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638634636?lang=en_us&edition=fundamental","pubTime":"2026-05-28 15:55","pubTimestamp":1779954956,"startTime":"0","endTime":"0","summary":"In a report released on May 26, Nicolas Pauillac from Kepler Capital upgraded GlaxoSmithKline to a Buy, with a price target of p2,516.00. According...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/positive-report-for-glaxosmithkline-gsk-from-kepler-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/positive-report-for-glaxosmithkline-gsk-from-kepler-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSKH","LU1829250122.USD","GSK.UK","BK4532","BK4007","BK4588","BK4585","GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638486682","title":"GSK’s Long-Acting HIV Study Nears the Finish Line: What Investors Should Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2638486682","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638486682?lang=en_us&edition=fundamental","pubTime":"2026-05-28 00:30","pubTimestamp":1779899412,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. GlaxoSmithKline (through ViiV Healthcare) has completed a Phase 3b stud...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsks-long-acting-hiv-study-nears-the-finish-line-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsks-long-acting-hiv-study-nears-the-finish-line-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4211","BK4581","LU1829250122.USD","BK4585","ISBC","BK4532","LABU","XLV","BK4007","GSK","XBI","BK4588","GSKH","GSK.UK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638689136","title":"GSK Discloses Notional ADS Purchase by US President Martinez-Davis","url":"https://stock-news.laohu8.com/highlight/detail?id=2638689136","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638689136?lang=en_us&edition=fundamental","pubTime":"2026-05-27 22:32","pubTimestamp":1779892342,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ( ($GB:GSK) ) just unveiled an announcement. GSK plc disclosed that Maya Martinez-Davis, its President for the US, acquired notiona...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-discloses-notional-ads-purchase-by-us-president-martinez-davis?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-discloses-notional-ads-purchase-by-us-president-martinez-davis?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK","BK4532","GSKH","LU1829250122.USD","BK4585","BK4007","GSK.UK","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638468990","title":"GlaxoSmithKline (GSK) Receives a Hold from Deutsche Bank","url":"https://stock-news.laohu8.com/highlight/detail?id=2638468990","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638468990?lang=en_us&edition=fundamental","pubTime":"2026-05-27 22:25","pubTimestamp":1779891919,"startTime":"0","endTime":"0","summary":"Deutsche Bank analyst Emmanuel Papadakis reiterated a Hold rating on GlaxoSmithKline today and set a price target of p1,900.00. Papadakis covers th...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-receives-a-hold-from-deutsche-bank-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-receives-a-hold-from-deutsche-bank-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4118","BK4566","BK4588","LU1829250122.USD","GSK","DB","BK4532","GSKH","BK4007","GSK.UK","BK4552","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638504632","title":"GlaxoSmithKline (GSK) Receives a Buy from Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2638504632","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638504632?lang=en_us&edition=fundamental","pubTime":"2026-05-27 18:57","pubTimestamp":1779879468,"startTime":"0","endTime":"0","summary":"In a report released today, Michael Leuchten from Jefferies maintained a Buy rating on GlaxoSmithKline, with a price target of £25.00. According to...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-receives-a-buy-from-jefferies-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-receives-a-buy-from-jefferies-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSKH","LU1829250122.USD","GSK.UK","BK4532","BK4007","BK4588","BK4585","GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638055549","title":"GSK to present new data from portfolio, pipeline at ASCO Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2638055549","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638055549?lang=en_us&edition=fundamental","pubTime":"2026-05-27 00:50","pubTimestamp":1779814240,"startTime":"0","endTime":"0","summary":"GSK (GSK) will present new data from its expanding oncology portfolio and pipeline at the 2026 American Society of Clinical Oncology, ASCO, Annual ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gsk-to-present-new-data-from-portfolio-pipeline-at-asco-annual-meeting-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gsk-to-present-new-data-from-portfolio-pipeline-at-asco-annual-meeting-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK","BK4532","GSKH","LU1829250122.USD","BK4585","BK4007","GSK.UK","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638254876","title":"GSK boosts treasury stock as buyback programme passes 3.3 million shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2638254876","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638254876?lang=en_us&edition=fundamental","pubTime":"2026-05-26 22:05","pubTimestamp":1779804309,"startTime":"0","endTime":"0","summary":"The latest announcement is out from GlaxoSmithKline ( ($GB:GSK) ). GSK has continued its share buyback programme, repurchasing around 1.67 million ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-boosts-treasury-stock-as-buyback-programme-passes-3-3-million-shares?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-boosts-treasury-stock-as-buyback-programme-passes-3-3-million-shares?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["US10Y.BOND","US12M.BOND","BK4585","US7Y.BOND","TLTW","GSK","GSK.UK","LU1829250122.USD","GSKH","BK4007","US3Y.BOND","BK4532","US30Y.BOND","TMF","BK4588","US5Y.BOND","TLT","US6M.BOND","US2Y.BOND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638548754","title":"GSK Adds Shares to Market Under Employee Save Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2638548754","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638548754?lang=en_us&edition=fundamental","pubTime":"2026-05-26 22:03","pubTimestamp":1779804192,"startTime":"0","endTime":"0","summary":"An announcement from GlaxoSmithKline ( ($GB:GSK) ) is now available. GSK has admitted 45,273 new ordinary shares of 31¼ pence each to trading on th...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-adds-shares-to-market-under-employee-save-plan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-adds-shares-to-market-under-employee-save-plan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK.UK","BK4585","BK4532","BK4007","BK4588","LU1829250122.USD","GSK","GSKH"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":200,"code":"91000000","status":"200"}]}}